Skip to main content
PBF logo

PBF — Investor Relations & Filings

Ticker · 1760 ISIN · TW0001760007 LEI · 54930078VUU2LBPR2729 TW Manufacturing
Open in API
Filings indexed 1,562 across all filing types
Latest filing 2022-01-13 Director's Dealing
Country TW Taiwan
Listing TW 1760

About PBF

http://www.pbf.com.tw

Panion & BF Biotech Inc. is a biotechnology company focused on pharmaceutical research, development, and manufacturing. Founded in 1976, the firm operates across several core sectors, including new drug innovation, medical aesthetics, and nutritional supplements. It is recognized for its "Total Aging Management" strategy, which addresses the health needs of an aging population through a diverse product portfolio. Key offerings include treatments for chronic kidney disease, specifically phosphate binders, as well as dermatological drugs, hair care solutions, and rapid diagnostic technologies. The company integrates clinical-grade pharmaceutical standards into its consumer health and aesthetic products, serving markets in chronic disease care and preventative wellness.

Recent filings

Filing Released Lang Actions
110年12月內部人持股異動(事後)
Director's Dealing Classification · 100% confidence The document consists of detailed tabular data showing shareholdings of insiders, including directors, managers, and their related parties. It lists share types, quantities held at different times, increases and decreases in holdings, and other related information. There is no indication of financial statements, earnings data, or management discussion. The content is focused on insider share transactions and holdings. This matches the definition of Director's Dealing (DIRS), which reports personal share transactions by company directors and executives (insider trades). The document length is sufficient and the content is substantive, not just an announcement or certification. Therefore, the appropriate classification is DIRS.
2022-01-13 Chinese
110年12月董事會成員及持股
Director's Dealing Classification · 95% confidence The document contains detailed tabular data about shareholdings and pledged shares of company insiders, including directors, independent directors, and senior management. It lists their current holdings, pledged shares, and related percentages. The content focuses on insider share transactions and holdings rather than financial results, management changes, or meeting materials. The document length is about 2933 characters, which is relatively short but contains substantive data on insider shareholdings. This matches the definition of Director's Dealing (DIRS), which reports personal share transactions by company directors and executives. There is no indication that this is an announcement of a report or a certification, so it is not RPA or RNS. Therefore, the best classification is DIRS.
2022-01-13 Chinese
110年12月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company, providing data on loan balances and guarantee information for the current and previous month, with amounts in New Taiwan Dollars. It does not contain comprehensive financial statements or detailed analysis, nor does it announce or attach a full report. The content is regulatory in nature, reporting specific financial data points likely required by a regulatory body. The document length is short (613 characters), and it is a straightforward regulatory disclosure without narrative or management discussion. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2022-01-10 Chinese
110年12月營業收入
Financial Supplement Data Classification · 85% confidence The document is a revenue summary report from a publicly listed company, showing monthly and cumulative net operating revenue figures with year-over-year comparisons. It includes notes on accounting standards (IFRS) and reporting practices. The document length is short (777 characters) and it primarily provides summarized financial data without detailed financial statements or analysis. It does not appear to be a full financial report like an Annual Report (10-K) or Interim Report (IR). It is also not an announcement of a report publication but a direct data disclosure. Given the nature of the content as a brief financial summary, it best fits the category of Financial Supplement Data (XLSX), which covers supplementary financial data in a concise format, even though this is not an Excel file, the content aligns with supplementary financial data rather than a full report or announcement.
2022-01-10 Chinese
代子公司正峰化學製藥股份有限公司公告董事會決議辦理 現金增資發行新股
Capital/Financing Update Classification · 100% confidence The document is a company announcement from a listed company (1760 寶齡富錦) regarding a board resolution to increase capital by issuing new shares through a cash capital increase. It details the number of shares, price, rights, subscription ratios, and related dates. The content focuses on financing activities and capital structure changes. The document length is short (960 characters) and it is not a report but an announcement of a financing event. Therefore, it fits the category of Capital/Financing Update (CAP).
2022-01-07 Chinese
澄清媒體有關本公司之報導
Regulatory Filings Classification · 95% confidence The document is a public clarification statement issued by the company 寶齡富錦生技股份有限公司 in response to media reports alleging price gouging of hand sanitizer products. It provides detailed explanations and corrective information to protect the company's reputation and inform investors. The document is short (1606 characters) and is a direct communication addressing a specific event rather than a financial report or regulatory filing. It does not contain financial statements, audit information, or management changes. It is not an announcement of voting results, dividend, or capital changes. It is a regulatory announcement clarifying facts to the public and investors, fitting the category of Regulatory Filings (RNS).
2022-01-02 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.